4.8 Review

The intrinsic and extrinsic effects of N-linked glycans on glycoproteostasis

期刊

NATURE CHEMICAL BIOLOGY
卷 10, 期 11, 页码 902-910

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nchembio.1651

关键词

-

资金

  1. National Institutes of Health [GM086874, GM094848]
  2. Chemistry-Biology Interface program training grant [GM08515]
  3. [DK075295]
  4. [AG046495]
  5. [GM051105]

向作者/读者索取更多资源

Proteins that traffic through the eukaryotic secretory pathway are commonly modified with N-linked carbohydrates. These bulky amphipathic modifications at asparagines intrinsically enhance solubility and folding energetics through carbohydrate-protein interactions. N-linked glycans can also extrinsically enhance glycoprotein folding by using the glycoprotein homeostasis or 'glycoproteostasis' network, which comprises numerous glycan binding and/or modification enzymes or proteins that synthesize, transfer, sculpt and use N-linked glycans to direct folding and trafficking versus degradation and trafficking of nascent N-glycoproteins through the cellular secretory pathway. If protein maturation is perturbed by misfolding, aggregation or both, stress pathways are often activated that result in transcriptional remodeling of the secretory pathway in an attempt to alleviate the insult (or insults). The inability to achieve glycoproteostasis is linked to several pathologies, including amyloidoses, cystic fibrosis and lysosomal storage diseases. Recent progress on genetic and pharmacologic adaptation of the glycoproteostasis network provides hope that drugs of this mechanistic class can be developed for these maladies in the near future.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

A circulating, disease-specific, mechanism-linked biomarker for ATTR polyneuropathy diagnosis and response to therapy prediction

Xin Jiang, Richard Labaudiniere, Joel N. Buxbaum, Cecilia Monteiro, Marta Novais, Teresa Coelho, Jeffery W. Kelly

Summary: This study investigated the diagnosis and treatment methods for TTR amyloidoses, highlighting the use of NNTTR in diagnosing FAP and the significant reduction of NNTTR levels in patients receiving treatment, even in nonresponders. High levels of NNTTR were associated with poor clinical response to the treatment.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Chemistry, Medicinal

Discovery of Potent Coumarin-Based Kinetic Stabilizers of Amyloidogenic Immunoglobulin Light Chains Using Structure-Based Design

Nicholas L. Yan, Diogo Santos-Martins, Reji Nair, Alan Chu, Ian A. Wilson, Kristen A. Johnson, Stefano Forli, Gareth J. Morgan, H. Michael Petrassi, Jeffery W. Kelly

Summary: The study identified drugs that could stabilize immunoglobulin light chains, suppressing protein aggregation through enhanced affinity. Analysis revealed potential stabilizers, which could improve the stability of the light chains, with some showing significant enhancement in affinity.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Multidisciplinary

Stereoelectronic effects in stabilizing protein-N-glycan interactions revealed by experiment and machine learning

Maziar S. Ardejani, Louis Noodleman, Evan T. Powers, Jeffery W. Kelly

Summary: The study demonstrates that stereoelectronic effects play a role in stabilizing protein-N-glycan interactions, with enthalpy-entropy compensation depending on the electronics of interacting side chains. Models using quantum mechanical calculations and machine learning can explain up to 79% and 97% of the experimental interaction energy variability.

NATURE CHEMISTRY (2021)

Article Multidisciplinary Sciences

Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia

Dorit Trudler, Kristopher L. Nazor, Yvonne S. Eisele, Titas Grabauskas, Nima Dolatabadi, James Parker, Abdullah Sultan, Zhenyu Zhong, Marshall S. Goodwin, Yona Levites, Todd E. Golde, Jeffery W. Kelly, Michael R. Sierks, Nicholas J. Schork, Michael Karin, Rajesh Ambasudhan, Stuart A. Lipton

Summary: Parkinson's disease is associated with the accumulation of alpha-synuclein and activation of microglia, potentially leading to neuronal death. This study shows that alpha-synuclein can activate NLRP3 inflammasome in human microglia and that alpha-synuclein-antibody complexes can exacerbate inflammation in a human context.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Biochemistry & Molecular Biology

Small molecule protein binding to correct cellular folding or stabilize the native state against misfolding and aggregation

Fabrizio Chiti, Jeffery W. Kelly

Summary: Protein misfolding diseases are caused by structural abnormalities in proteins, and specific small molecules have been approved to stabilize the folded state of these proteins, providing a promising approach to treat such diseases.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2022)

Article Chemistry, Medicinal

Amyloidogenic immunoglobulin light chain kinetic stabilizers comprising a simple urea linker module reveal a novel binding sub-site

Nicholas L. Yan, Reji Nair, Alan Chu, Ian A. Wilson, Kristen A. Johnson, Gareth J. Morgan, Jeffery W. Kelly

Summary: This study investigates the potential of finding small molecule kinetic stabilizers in immunoglobulin light chain amyloidosis, identifying coumarin-based compounds with potential therapeutic effects. Structural-activity relationship data reveals that these compounds bind at different sites in the LC dimer, exerting unique stabilizing effects on LCs.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)

Review Biochemistry & Molecular Biology

Inverse Drug Discovery identifies weak electrophiles affording protein conjugates

Gabriel M. Kline, Karina Nugroho, Jeffery W. Kelly

Summary: In this review, we examine the application of Inverse Drug Discovery method using organic compounds of intermediate complexity harboring Sulfur(VI)-fluoride exchange (SuFEx) electrophiles to expand the cellular proteins that can be targeted covalently.

CURRENT OPINION IN CHEMICAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Pharmacological activation of ATF6 remodels the proteostasis network to rescue pathogenic GABAA receptors

Meng Wang, Edmund Cotter, Ya-Juan Wang, Xu Fu, Angela L. Whittsette, Joseph W. Lynch, R. Luke Wiseman, Jeffery W. Kelly, Angelo Keramidas, Ting-Wei Mu

Summary: This study demonstrates that pharmacologically enhancing endoplasmic reticulum (ER) proteostasis can increase the assembly, trafficking, and surface expression of variant GABA(A) receptors, offering a potential opportunity to mitigate pathology associated with genetic epilepsy and other disease-associated variant ion channels.

CELL AND BIOSCIENCE (2022)

Article Cell Biology

ATF6 Activation Reduces Amyloidogenic Transthyretin Secretion through Increased Interactions with Endoplasmic Reticulum Proteostasis Factors

Jaleh S. Mesgarzadeh, Isabelle C. Romine, Ethan M. Smith-Cohen, Julia M. D. Grandjean, Jeffery W. Kelly, Joseph C. Genereux, R. Luke Wiseman

Summary: This study identified ER proteostasis factors involved in ATF6-dependent reductions in destabilized TTR secretion through a mass-spectrometry-based interactomics approach. Activation of ATF6 reduces the secretion and subsequent aggregation of amyloidogenic TTR through increased interactions with ATF6-regulated ER proteostasis factors including BiP and PDIA4. PDIA4 retains destabilized TTR in the ER through a redox-independent mechanism. These findings provide a mechanistic basis for the therapeutic targeting of ATF6 activation to improve treatments for TTR-related amyloid diseases.
Article Geriatrics & Gerontology

Analysis of lumbar spine stenosis specimens for identification of amyloid

Mathew S. Maurer, Dia Smiley, Eli Simsolo, Fabrizio Remotti, Angela Bustamante, Sergio Teruya, Stephen Helmke, Andrew J. Einstein, Ronald Lehman, Jon T. Giles, Jeffery W. Kelly, Felix Tsai, William S. Blaner, Pierre-Jacques Brun, Ron Riesenburger, James Kryzanski, Cindy Varga, Ayan R. Patel

Summary: Lumbar spinal stenosis (LSS) is a common reason for spine surgery in older adults, with amyloid detected in over one third of patients, especially in those over 75 years old. Age, clinical symptoms, cardiac biomarkers, and other parameters did not differ significantly between patients with and without amyloid.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2022)

Article Biochemistry & Molecular Biology

Tafamidis polyneuropathy amelioration requires modest increases in transthyretin stability even though increases in plasma native TTR and decreases in non-native TTR do not predict response

Cecilia Monteiro, Jaleh S. Mesgarzadeh, Joao Anselmo, Joana Fernandes, Marta Novais, Carla Rodrigues, David L. Powers, Evan T. Powers, Teresa Coelho, Jeffery W. Kelly

Summary: This study explored the relationship between TTR stabilization markers and clinical efficacy of tafamidis treatment. The results showed an increase in native TTR concentration and a decrease in non-native TTR concentration. However, changes in native and non-native TTR levels were not correlated with clinical response to tafamidis. Successful tafamidis therapy requires moderate TTR stabilization, and male patients may benefit from higher doses of tafamidis.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2023)

Article Biochemistry & Molecular Biology

Characterising diflunisal as a transthyretin kinetic stabilizer at relevant concentrations in human plasma using subunit exchange

Felix J. J. Tsai, Luke T. T. Nelson, Gabriel M. M. Kline, Marcus Jager, John L. L. Berk, Yoshiki Sekijima, Evan T. T. Powers, Jeffery W. Kelly

Summary: This study investigated the plasma concentrations of diflunisal and its efficacy in treating TTR polyneuropathy, finding that at a certain concentration, diflunisal can effectively slow down TTR dissociation rate and inhibit aggregation.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2023)

Article Biochemistry & Molecular Biology

Tafamidis concentration required for transthyretin stabilisation in cerebrospinal fluid

Felix J. Tsai, Marcus Jaeger, Teresa Coelho, Evan T. Powers, Jeffery W. Kelly

Summary: This study investigates whether adding tafamidis to cerebrospinal fluid (CSF) stabilizes the TTR protein in healthy donors and patients with hereditary transthyretin amyloidosis (ATTRv). The results show that tafamidis can stabilize the TTR protein in CSF to a clinically meaningful extent.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2023)

Article Biochemistry & Molecular Biology

Divergent Proteome Reactivity Influences Arm-Selective Activation of the Unfolded Protein Response by Pharmacological Endoplasmic Reticulum Proteostasis Regulators

Gabriel M. Kline, Ryan J. Paxman, Chung-Yon Lin, Nicole Madrazo, Leonard Yoon, Julia M. D. Grandjean, Kyunga Lee, Karina Nugroho, Evan T. Powers, R. Luke Wiseman, Jeffery W. Kelly

Summary: AA132 activates the unfolded protein response (UPR) by metabolically activating and covalently modifying proteins, particularly PDIs, more extensively than AA147. The lower reactivity of activated AA132 allows it to persist longer and modify more proteins, leading to a global UPR activation.

ACS CHEMICAL BIOLOGY (2023)

暂无数据